The addition of ribavirin to interferon-α therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism

Carlo Carella, Gherardo Mazziotti, Filomena Morisco, Mario Rotondi, Michele Cioffi, Concetta Tuccillo, Francesca Sorvillo, Nicola Caporaso, Giovanni Amato

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'The addition of ribavirin to interferon-α therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism'. Together they form a unique fingerprint.

Medicine & Life Sciences